We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cepheid Expands Distribution into Latin America

By HospiMedica staff writers
Posted on 22 Apr 2004
Following the signing of multi-year distribution agreements, Cepheid (Sunnyvale, CA, USA; www.cepheid.com) has announced the company will market its SmartCycler portable laboratory system along with accessories and disposables in Mexico and Brazil.

The SmartCycler is a thermal cycler with real-time optical detection that can be used to quickly and accurately detect infectious disease agents, human genes, and industrial or environmental contamination. Cepheid signed marketing agreements with BioAgency Co. Ltd. (Sao Paulo, Brazil) and Industrias Bioselec S.A. de C.V. (Mexico City, Mexico). Both companies will provide marketing, sales, and service support for the SmartCycler product line.

"Both BioAgency and Biocelec are companies that have a well-earned reputation as quality business units that maintain high standards of customer service,” noted Ira Marks, vice president, worldwide sales & marketing, Cepheid. "These relationships will help to strongly position Cepheid's products in selected Latin American territories and will enhance Bioagency's and Bioselec's roles in the developing life science and genomic testing markets.




Related Links:
Cepheid

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Drug Testing Assays
Atellica DT 250 Analyzer
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
22 Apr 2004  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
22 Apr 2004  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
22 Apr 2004  |   Industry